HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Glossier Announces $80m Financing: ‘This Is The Future We’ve Always Been Building For’

Executive Summary

Having started a decade ago as a beauty blog, Glossier now markets around 40 products across beauty and personal-care categories in the US and internationally with the same modus operandi: “We create the products you tell us you wish existed.” The company will use new funding, in part, to open new Glossier stores after shuttering its owned retail operations in 2020 due to COVID.

You may also be interested in...

VC Funding For US Beauty Companies At Record High Already In 2018

Venture capitalists are racing to get a piece of emerging direct-to-consumer beauty and personal-care businesses, investing $812m in such companies in 2018 so far, according to data compiled by software-as-a-service firm Pitchbook.

Beauty Supply Chain Pains Haven’t Snuffed Sustainability Push; ‘The Opposite,’ Says IBA

“There's a lot of creativity and innovation that's being forced” by supply chain challenges, according to Elizabeth Corrigan, recently appointed chairwoman of the Independent Beauty Association. IBA’s Akemi Ooka says smaller companies looking to engage on sustainability can be well-served to start with supply chain assessment.

ECHA: Registrants Using Skin Sensitization Alt Methods Should Update Dossiers Using OECD 497

The agency is aware of more than 14,000 substances on the EU market with some indication of skin-sensitization concern. Using the OECD guideline, adopted in June, registrants may be able to make conclusive predictions without use of animals and should update REACH dossiers accordingly.





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts